Dermatology · Philadelphia, PA
NPI
1154610889
Since 2011
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
3400 Spruce St, 1 Dulles Building
Philadelphia, PA, 19104
Phone (215) 662-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
359 services
Medicare patients, 2024
191
Average age 74
Drug cost, 2024
$2.8M
1,066 prescriptions
Company payments, 2024
$7,514
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan H Noe was code 99214 (office e&m - established), 189 times for 126 patients. In total Megan H Noe billed 359 services in 15 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 189 | 126 | $70.06 | $13K |
| 99213 Office E&M - Established | Office | 80 | 77 | $46.28 | $3,703 |
| 11102 Skin Biopsy | Office | 15 | 15 | $24.29 | $364 |
| 17000 Destruction Skin Lesion | Office | 14 | 13 | $41.64 | $583 |
| 17110 Destruction Skin Lesion | Office | 13 | 12 | $61.20 | $796 |
| 99204 Office E&M - New | Office | 11 | 11 | $102.47 | $1,127 |
By year: 2022 $13K for 229 services; 2023 $23K for 368 services; 2024 $21K for 359 services.
Medicare prescription drug claims, 2024
In 2024, the drug Megan H Noe prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 269 prescriptions and refills. In total Megan H Noe wrote 1,066 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 269 | 274 | 29 | $982K |
| Dupixent Syringe Dupilumab | 98 | 99 | Under 11 | $363K |
| Methotrexate Methotrexate Sodium | 69 | 103 | 16 | $1,098 |
| Ketoconazole Generic | 55 | 61 | 21 | $1,079 |
| Prednisone Generic | 41 | 55 | 22 | $212 |
| Triamcinolone Acetonide Generic | 38 | 48 | 21 | $700 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 31 | 31 | Under 11 | $511K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 26 | 32 | 12 | $1,581 |
| Doxycycline Monohydrate Generic | 26 | 38 | Under 11 | $763 |
| Dapsone Generic | 24 | 51 | Under 11 | $1,930 |
| Clobetasol Propionate Generic | 21 | 21 | 15 | $1,522 |
| Fluocinonide Generic | 21 | 21 | Under 11 | $1,567 |
| Dexamethasone Generic | 19 | 19 | Under 11 | $676 |
| Skyrizi Pen Risankizumab-Rzaa | 19 | 48 | Under 11 | $372K |
| Otezla Apremilast | 19 | 19 | Under 11 | $85K |
Brand drugs: 533 claims; generic drugs: 533 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Megan H Noe $7,514 ($7,514 in general payments such as food, travel and fees) from 3 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $5,058.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.